Angiogenic Gene Therapy (AGENT) Trial in Patients With Stable Angina Pectoris
Top Cited Papers
- 19 March 2002
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Circulation
- Vol. 105 (11) , 1291-1297
- https://doi.org/10.1161/hc1102.105595
Abstract
Background— The angiogenic response to myocardial ischemia can be augmented in animal models by gene transfer with the use of a replication defective adenovirus (Ad) containing a human fibroblast g...Keywords
This publication has 15 references indexed in Scilit:
- Catheter-Mediated Vascular Endothelial Growth Factor Gene Transfer to Human Coronary Arteries after AngioplastyHuman Gene Therapy, 2000
- Cardiovascular gene therapyThe Lancet, 2000
- Adenovirus vectors for gene deliveryCurrent Opinion in Biotechnology, 1999
- Percutaneous Transluminal Coronary Angioplasty Versus Medical Therapy for Stable Angina Pectoris: Outcomes for Patients With Double-Vessel Versus Single-Vessel Coronary Artery Disease in a Veterans Affairs Cooperative Randomized TrialPublished by Elsevier ,1999
- Intracoronary gene transfer of fibroblast growth factor–5 increases blood flow and contractile function in an ischemic region of the heartNature Medicine, 1996
- “Sero-Switch” Adenovirus-MediatedIn VivoGene Transfer: Circumvention of Anti-Adenovirus Humoral Immune Defenses Against Repeat Adenovirus Vector Administration by Changing the Adenovirus SerotypeHuman Gene Therapy, 1996
- Asymptomatic Cardiac Ischemia Pilot (ACIP) StudyCirculation, 1995
- Transient Expression of Genes TransferredIn Vivointo Heart Using First-Generation Adenoviral Vectors: Role of the Immune ResponseHuman Gene Therapy, 1995
- Basic fibroblast growth factor improves myocardial function in chronically ischemic porcine hearts.Journal of Clinical Investigation, 1994
- Effects of coronary artery bypass surgery and angioplasty on the total ischemic burden: A study of exercise testing and ambulatory ST segment monitoringAmerican Heart Journal, 1992